Search
for
Sort by
Research 31–60 of 1000+
- Effectiveness and safety of physician–pharmacist collaborative care for rheumatoid arthritis patients: The Changi General Hospital’s experience
- Contents
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Biologic Therapies and Small-Molecule Inhibitors for Dissecting Cellulitis of the Scalp: A Systematic Review
- Dermatological medications and local therapeutics
- Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy
- Effects of local and systemic medications on eye health: Adverse reactions
- Cuantificación, caracterización química y biológica del contenido saponósido de Sida cordifolia L. (escobilla)
- Biologics in the management of childhood atopic dermatitis
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Emerging Therapies for Acne Vulgaris
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Geriatric Dermatologic Therapy
- Biologic: A Double Edged Sword - A Case of Etanercept Induced Alopecia Areata in a Patient with Psoriasis Vulgaris
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- Cutaneous Manifestations of Lupus Erythematosus
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- Lupus erythematosus: systemic and cutaneous manifestations
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Drug-induced acne
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Immune cell regulation of the hair cycle
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Secondary cicatricial and other permanent alopecias
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Management of Toxicities of Targeted Therapies
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata